Report

Global Medical Marijuana Market Size study & Forecast, by Formulation Type (Capsules, Oils, and Other Formulation Types) by Application (Chronic Pain, Arthritis, Migraine, Cancer, and Other Applications) and Regional Analysis, 2022-2029

  • Publish Date: Nov,2022
  • Report ID: 3-2-1151
  • Page : 200
  • Report Type : PDF (Email)
Global Medical Marijuana Market is valued approximately at USD 11.0 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 21.06% over the forecast period 2022-2029. Medical marijuana, also referred to as medical cannabis, is derived from the Cannabis sativa plant which is also used to treat a disease or specific symptom such as cancer, chronic pain, mental disorders, and manage pain. Cannabis Sativa and Cannabis Indica, which come from the western hemisphere and central and south Asian regions, respectively, are the two types of medical marijuana. The key factors driving the market growth is rising awareness about benefits of medical marijuana, growing legalization of cannabis across region and growing FDA approvals for medicinal cannabis products.

In 2018, FDA approved the first drug comprising of an active component derived from marijuana for treating epilepsy. Epidiolex (cannabidiol) [CBD] in oral solution was granted this approval to treat seizures related to two severe and rare forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome. In January 2018, the Australian Government allowed marijuana producers in the country to export medical marijuana and its products to the global medical marijuana market. Also, innovative product development with growing R&D activities will create lucrative opportunities for the market during forecast period. However, the complex regulatory structure for the usage of cannabis stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Medical Marijuana Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the rising cannabis legalization in the U.S. This is one of the key factors contributing to its growing demand. Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as increasing legalization of cannabis as well as an increase in disposable income, social acceptance, and consumer understanding of the product's advantages.

Major market players included in this report are:

Tilray

Aurora Cannabis

Canopy Growth Corporation

Aphria, Inc.

Maricann Group, Inc.

Tikun Olam, Ltd.

MedReleaf. Corp.

GW Pharmaceuticals plc.

Cannabis Sativa, Inc.

Medical Marijuana, Inc.

Recent Developments in the Market:

In Feb. 2022, Bombay Hemp Company, an agro company, joined along with Poonthottam Ayurvedasram to utilize the medicinal properties of cannabis for modern use. Asia's first Ayurvedic Cannabis Wellness Retreat is a partnership under the name "AyurCann: Ayurvedic Cannabis Therapies."
In April 2022, MediCane Health Inc. and Dr. Reddy's Laboratories Ltd. introduced their medicinal marijuana product in Germany.
Global Medical Marijuana Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered Formulation Type, Application, Region

Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Formulation Type:

Capsules

Oils

Other Formulation Types

By Application:

Chronic Pain

Arthritis

Migraine

Cancer

Other Applications

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World